Atyr Pharma Inc (NASDAQ: ATYR) on Friday, soared 0.56% from the previous trading day, before settling in for the closing price of $5.35. Within the past 52 weeks, ATYR’s price has moved between $1.42 and $5.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -11.05% over the last five years. The company achieved an average annual earnings per share of 28.86%. With a float of $86.06 million, this company’s outstanding shares have now reached $89.00 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Atyr Pharma Inc is 3.31%, while institutional ownership is 69.43%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.86% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Atyr Pharma Inc (ATYR) is currently performing well based on its current performance indicators. A quick ratio of 7.79 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Analysing the last 5-days average volume posted by the [Atyr Pharma Inc, ATYR], we can find that recorded value of 3.73 million was better than the volume posted last year of 1.45 million. As of the previous 9 days, the stock’s Stochastic %D was 77.47%. Additionally, its Average True Range was 0.37.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 89.28%, which indicates a significant increase from 85.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.24% in the past 14 days, which was lower than the 87.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.49, while its 200-day Moving Average is $3.15. Now, the first resistance to watch is $5.49. This is followed by the second major resistance level at $5.60. The third major resistance level sits at $5.67. If the price goes on to break the first support level at $5.30, it is likely to go to the next support level at $5.23. Now, if the price goes above the second support level, the third support stands at $5.12.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
Market capitalization of the company is 478.84 million based on 89,004K outstanding shares. Right now, sales total 240 K and income totals -64,020 K. The company made 0 K in profit during its latest quarter, and -14,880 K in sales during its previous quarter.
